Literature DB >> 9692161

Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children.

A Sowunmi1, A M Oduola, O A Ogundahunsi, L A Salako.   

Abstract

The efficacy of pyrimethamine/sulfadoxine (PS) and chloroquine plus chlorpheniramine, a histamine H1 receptor blocker which reverses chloroquine insensitivity in Plasmodium falciparum in vitro, was evaluated in 100 consecutive children with acute symptomatic uncomplicated falciparum malaria. Parasitaemia on day 3 following initiation of treatment, fever and symptom clearance times were significantly lower in the chloroquine/chlorpheniramine (CQ/CP) combination group than in the PS group. The cure rate was also significantly higher in the combination group. The combination cured all children who had failed PS treatment. Gametocytaemia and the gametocyte carrier rate following therapy were significantly lower in the combination group than in those receiving PS. Both treatments were well tolerated but adverse drug reactions were commoner in the children given PS. CQ/CP is effective in PS treatment failure in Nigerian children and may be useful for this condition in African children in general.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692161     DOI: 10.1016/s0035-9203(98)90964-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

Review 1.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

2.  Potent enhancement of the sensitivity of Plasmodium falciparum to chloroquine by the bisbenzylisoquinoline alkaloid cepharanthin.

Authors:  K Haruki; P G Bray; M Ono; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children.

Authors:  Akintunde Sowunmi; Elsie O Adewoye; Grace O Gbotsho; Christian T Happi; Abayomi Sijuade; Onikepe A Folarin; Titilope M Okuboyejo; Obaro S Michael
Journal:  Malar J       Date:  2010-02-15       Impact factor: 2.979

4.  Cotrimoxazole in the treatment of acute uncomplicated falciparum malaria in nigerian children : a controlled clinical trial.

Authors:  F A Fehintola; A A Adedeji; E Tambo; B B Fateye; T C Happi; A Sowunmi
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

5.  Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents.

Authors:  Julie Millet; Marylin Torrentino-Madamet; Sandrine Alibert; Christophe Rogier; Christiane Santelli-Rouvier; Joel Mosnier; Eric Baret; Jacques Barbe; Daniel Parzy; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.